Futura Medical plc (AIM:FUM)

Market Cap	7.54M
Revenue (ttm)	7.93M
Net Income (ttm)	-6.29M
Shares Out	581.33M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,056,807
Average Volume	13,146,564
Open	1.350
Previous Close	1.243
Day's Range	1.150 - 1.350
52-Week Range	0.989 - 32.450
Beta	0.49
RSI	45.11
Earnings Date	Apr 10, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM